Quantcast
Last updated on April 23, 2014 at 11:05 EDT

Latest Attenuated vaccine Stories

2013-12-26 08:21:16

DUBLIN, December 26, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qv4xvl/animalveterinary) has announced the addition of the "International Animal/Veterinary Vaccines Market 2013-2018" [http://www.researchandmarkets.com/research/qv4xvl/animalveterinary ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Europe accounts for the largest share of the veterinary vaccines market, followed...

Molecular Biomarkers Of Vaccine Immunity Identified
2013-12-16 12:33:15

Emory University Testing the efficacy of vaccines in clinical trials takes years, even decades. Yet challenging infections like HIV, malaria and dengue are striking today. To speed up vaccine testing, scientists at the Emory Vaccine Center have established a goal of creating a “vaccine gene chip.” This device could read the activity of all the genes in the genome in white blood cells within a few days of administration of a test vaccine. Reading such “molecular signatures” would...

2013-10-07 23:21:36

Animal Vaccines Market (Veterinary Vaccines) report categorizes the global animal vaccines market on the basis of products, animal diseases, and technology. http://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html (PRWEB) October 07, 2013 The “Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA,...

Mutant Strain Created From MERS-CoV May Offer Potential Vaccine
2013-09-10 12:56:57

Lawrence LeBlond for redOrbit.com - Your Universe Online Scientists working to find a vaccine and cure for the Middle East Respiratory Syndrome (MERS) coronavirus may have taken a huge step in the right direction. Publishing details in the open-access journal mBio, researchers, led by Luis Enjuanes of the Autonomous University of Madrid, developed a strain of MERS-CoV that may be used as a vaccine against a disease that has so far killed roughly half of all infected patients....

Measles Vaccine Using A Microneedle Patch Could Boost Immunization Programs
2012-11-27 19:10:00

Georgia Institute of Technology Research News Measles vaccine given with painless and easy-to-administer microneedle patches can immunize against measles at least as well as vaccine given with conventional hypodermic needles, according to research done by the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC). In the study, the researchers developed a technique to dry and stabilize the measles vaccine — which depends on a live attenuated virus...

2012-11-13 12:17:19

Rapid mutation has long been considered a key to viral adaptation to environmental change. But in the case of the coronavirus responsible for deadly severe acute respiratory syndrome (SARS), collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations cripples the virus's ability to cause disease in animals. In addition, they say this finding may allow scientists to explore a new option for creating safer live...

Universal Platform For Delivering Highly Potent DNA Vaccines
2012-11-06 10:20:55

Connie K. Ho for redOrbit.com — Your Universe Online Researchers from Arizona State University (ASU) recently revealed novel technology that could help protect against a number of pathogens at lower costs and with improved methods. A re-engineered bacterium that can quicken the delivery of the DNA vaccines to host cells, the new platform was found to provide complete protection against influenza in mice. The team of investigators believes that the new technique could be...

2012-09-18 02:27:19

BEIJING, Sept. 18, 2012 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today that it has received GMP certification from the China State Food and Drug Administration (SFDA) for the Company's dedicated mumps vaccine production plant at its Sinovac Dalian facility. The SFDA issued a public announcement on September 12, 2012, stating that the Good Manufacturing Practices (GMP) certification was issued to Sinovac with the certificate...

2012-07-13 10:34:12

Research from the University of Melbourne has shown that two different vaccine viruses- used simultaneously to control the same condition in chickens- have combined to produce new infectious viruses, prompting early response from Australia's veterinary medicines regulator. The vaccines were used to control infectious laryngotracheitis (ILT), an acute respiratory disease occurring in chickens worldwide. ILT can have up to 20% mortality rate in some flocks and has a significant economic and...

shutterstock_93016576
2012-07-13 10:37:54

Brett Smith for redOrbit.com - Your Universe Online Australian scientists looking to vaccinate chicken populations against a respiratory disease may have accidentally unleashed a disease far more deadly than the one they hoped to prevent. According to a report published this week in Science, the genomes from two different strains of the herpesvirus infectious laryngotracheitis (ILT) virus that were used in vaccines have recombined to produce more virulent ILT viruses near Sydney and...